Clinical Study

Naturalistic Study On Treatment Response In Pd

Posted Date: Oct 26, 2014

  • Investigator: Alberto Espay
  • Co-Investigator: Catherine Krier
  • Specialties: Parkinson's Disease, Neurology, Movement Disorders
  • Type of Study: Observational/Survey

The purpose of this research study is to examine whether Parkinson’s drugs such as, L-dopa, selegiline, rasagiline, Pramipexole (PPX) and Ropinirole (RPN), have an effect on your motor impairment. All medications that you may receive during this study are FDA approved to treat motor function problems in people with Parkinson’s disease.

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are Between The Ages Of 35 And 80, You Have Been Diagnosed With Parkinson’S Disease And You Need To Start Taking A New Drug To Improve Your Motor Function.These Drugs May Be A Dopamine Agonist Such As Ppx Or Rpn, Or L-Dopa, Selegiline, Or Rasagiline. You Will Not Be Asked To Participate In The Study If You Have Begun Treatment With Dopamine Agonists, Antipsychotic Or Antidepressant Drugs Within Three Months Of Enrollment.

Keywords:

Motor Function Problems, Depression, Motor Impairment, Parkinson's Disease, Espay

For More Information:

Enrique Urrea
(513) 289-9428
urreamee@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant